Business Context and Reporting Period
Company: Colgate-Palmolive Company
Filing Type: Form 8-K (Current Report)
Date of Report: March 17, 2026
Reporting Period: Effective for the quarter ending March 31, 2026
This filing announces a realignment of reportable operating segments as part of the company's Strategic Growth and Productivity Program. The changes are designed to optimize operating scale and drive growth within the Europe and Africa/Eurasia regions.
Key Financial Metrics
The filing does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document explicitly states that the segment realignment did not impact the Company's historical consolidated results of operations, financial position, or cash flows.
Material Changes Versus Prior Period
The primary material change is a restructuring of geographic and business segment reporting, effective for the quarter ending March 31, 2026:
- New Segment Formation: A new "Europe, Middle East and Africa" reportable operating segment has been created. This combines the previous Europe and Africa/Eurasia segments (excluding Russia and Belarus) with the Skin Health business (previously reported within North America).
- Reclassification of Russia and Belarus: Operations in Russia and Belarus, previously reported within the Africa/Eurasia segment, are now reported within the Asia Pacific segment.
- Historical Recasting: The Company has recast historical geographic segment information for the years ended December 31, 2025, 2024, and 2023, as well as interim periods in 2025, to conform to the new structure. This is for informational purposes and does not constitute a restatement of previously issued financial statements.
Guidance, Outlook, and Management Commentary
Management Commentary: The segment changes are driven by the Strategic Growth and Productivity Program to better leverage operating scale. Management emphasizes that these changes have no impact on consolidated financial results.
Outlook and Risks: The filing does not contain updated financial guidance, specific risk factors, or contingencies related to this event. Investors are directed to read this information in conjunction with the Annual Report on Form 10-K for the year ended December 31, 2025.
Important Facts for Investor Verification
- Verify the recast segment data provided in Exhibit 99 to understand the new composition of the "Europe, Middle East and Africa" and "Asia Pacific" segments.
- Confirm that consolidated financial metrics (revenue, net income, cash flow) remain unchanged despite the segment reclassification.
- Review the Form 10-K for the year ended December 31, 2025, for the full context of the Strategic Growth and Productivity Program.
- Note that the Skin Health business has moved from the North America segment to the new Europe, Middle East and Africa segment.